Blog

Top 10 Pharmaceutical Therapy Areas in 2017

Top 10 Pharmaceutical Therapy Areas in 2017

Many new medications and treatments have emerged this year for improving the management and prognoses of patients suffering from serious diseases. Driven growing therapy areas such as oncology, anti-rheumatics, and anti-virals, the prescription drug sales are increasing significantly. Let’s take a quick look at the top pharmaceutical therapy areas in 2017: Oncology Oncology is maintaining … Continue reading Top 10 Pharmaceutical Therapy Areas in 2017

Top Pharma News - IgeaHub

Top Pharma News of the Week

Repatha® (Evolocumab) Phase 3 Cognitive Function Study Results Published In The New England Journal Of Medicine August 16, 2017 Amgen has announced that the New England Journal of Medicine (NEJM) published results from the Repatha® (evolocumab) cognitive function trial (EBBINGHAUS), which was conducted in a subset of patients enrolled in the randomized, placebo-controlled Repatha cardiovascular outcomes study (FOURIER). The … Continue reading Top Pharma News of the Week

Medical Science Liaison (MSL): Why Pharmacists make a good (or even better) MSL candidate

The Medical Science Liaison (MSL) role is often associated with PhDs, postdocs and in some counties with an MD degree. But we know from our 2017 global MSL salary survey that quite a few MSLs globally have a pharmacist background. For instance, in the US and Portugal, 27% and 22% of the MSLs had a … Continue reading Medical Science Liaison (MSL): Why Pharmacists make a good (or even better) MSL candidate

Top Pharma News - IgeaHub

Top Pharma News of the Week

FibroGen Announces Positive Topline Results from Phase 2 Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis Aug. 07, 2017 FibroGen, Inc., a science-based biopharmaceutical company, has announced positive topline results from the company’s Phase 2 randomized, double-blind, placebo-controlled study and two combination safety sub-studies of pamrevlumab in patients with idiopathic pulmonary fibrosis (IPF). Pamrevlumab is a proprietary, … Continue reading Top Pharma News of the Week

Top 10 Oncology Pharmaceutical Companies 2017

Top 10 Oncology Pharmaceutical Companies 2017

The market for oncology medication is booming, aiding the overall pharmaceutical industry growth. The oncology drug market is estimated to be almost USD 94 billion. Most of the top pharmaceutical players are either currently manufacturing oncology drugs or have oncology medications in their R&D pipelines. An analysis of the top pharmaceutical companies was conducted to … Continue reading Top 10 Oncology Pharmaceutical Companies 2017

Top 20 Drugs in the World 2017

Top 20 Drugs in the World 2017

The global prescription drug market is expected to grow by 6% from 2016 to 2022 to reach nearly USD 1.05 trillion by 2022. The top 20 drugs are manufactured by 14 companies and account for a total 10% of global prescription drug market in 2016. The total revenue generated by top 20 products was estimated … Continue reading Top 20 Drugs in the World 2017

Top Pharma News - IgeaHub

Top Pharma News of the Week

Amgen Submits Supplemental Biologics License Application for Prolia® (denosumab) In Glucocorticoid-Induced Osteoporosis  July 31, 2017 Amgen has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Prolia® (denosumab) for the treatment of patients with glucocorticoid-induced osteoporosis (GIOP). The sBLA is based on a Phase 3 study evaluating the … Continue reading Top Pharma News of the Week

The World’s Healthiest Countries 2017

The World’s Healthiest Countries 2017

Also this year Bloomberg published the ranking of the 50 healthiest countries in the world and results are quite surprising. The Bloomberg Global Health Index is calculated taking into account variables such as life expectancy, causes of death, incidence of high blood pressure, high blood glucose, tobacco use, and physical inactivity. Other parameters taken into … Continue reading The World’s Healthiest Countries 2017

Top Pharma News - IgeaHub

Top Pharma News | July – August 2017

Phase 3 Study Evaluating the Safety and Efficacy of Adjuvant Opdivo in Resected High-Risk Melanoma Patients Meets Primary Endpoint July 5, 2017 Bristol-Myers Squibb Company has announced that a Phase 3 study evaluating Opdivo 3 mg/kg versus Yervoy 10 mg/kg in patients with stage IIIb/c or stage IV melanoma who are at high risk of recurrence following complete surgical resection met its … Continue reading Top Pharma News | July – August 2017

Cancer Medication Market – A blockbuster area for investment

Cancer is one of the leading causes of morbidity and mortality worldwide, but therapeutic innovation has changed the treatment paradigm drastically. Cancer medication demand is increasing due to high unmet medical need and incidence rate. This reflects in growing revenues for pharmaceutical companies operating in this space and increasing investments in oncology R&D. The key … Continue reading Cancer Medication Market – A blockbuster area for investment